Solana Company
NASDAQ:HSDTMedical - Devices
+$0.01 today
- Market cap
- $95.17M
- Beta
- 1.03
- P/E (TTM)
- -0.9
- EPS (TTM)
- -$1.78
Volume 0.23M
Average 0.38M
HSDT Common Stock Issued
Cash raised by issuing new shares.
Solana CompanyNASDAQ: HSDT
Common Stock Issued · Q1 FY2026 · quarter ended Mar 2026
Common stock issued outflow shrinks to $0
Q1 FY2026 common stock issued was $0, compared with $77K a year earlier. Trailing-twelve-month common stock issued was $443.63M. Over 3 fiscal years it compounded at +196.8% a year.
Context
- Common stock issued amounted to 7761.8% of revenue in FY2025, up 6424.5 pp from a year earlier.
- Common stock issued increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly common stock issued holds near $0 or moves back toward the trailing-twelve-month quarterly average of $110.91M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Common Stock Issued history
USD · from the cash flow
- Latest · FY2025
- 467.03M USD
- Year-over-year change
- +6615.9%
- 4-year CAGR
- +116.8%
| Period | Period end | Common Stock Issued | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 467.03M | +6615.9% |
| FY2024 | 2024-12-31 | 6.95M | +545.7% |
| FY2023 | 2023-12-31 | 1.08M | -94.0% |
| FY2022 | 2022-12-31 | 17.87M | -15.4% |
| FY2021 | 2021-12-31 | 21.13M | — |
Common Stock Issued vs competitors
How HSDT compares with its peers on the latest reported figures
- HSDT's LTM Mar 2026 common stock issued of $443.63M is the largest of the 11 companies compared; the peer median is $632.5K.
- Its year-over-year change of +29182.4% is the highest of 9, against a peer median of -35.8%.
- Common stock issued amounts to 4626.4% of revenue for HSDT, versus a peer median of 0.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $443.63M | +29182.4% | +196.8% | 4626.4% | |
| LTM Mar 2026 | $164.38M | -29.1% | — | 26598.5% | |
| LTM Mar 2026 | $65.24M | +414.7% | — | 145.3% | |
| LTM Mar 2026 | $43.19M | +10.3% | — | 228.9% | |
| LTM Dec 2025 | $22.66M | -42.6% | +182.4% | 174.0% | |
| LTM Mar 2026 | $855K | -96.9% | +153.3% | 0.2% | |
| LTM Mar 2026 | $410K | -75.8% | -31.6% | 0.3% | |
| LTM Mar 2026 | $360K | — | — | 0.3% | |
| LTM Mar 2026 | $353K | +100.5% | +172.2% | 0.3% | |
| LTM Mar 2026 | $322K | — | +77.2% | 0.7% | |
| LTM Mar 2026 | $112K | -70.6% | — | 0.2% | |
| Peer median (excluding HSDT) | $632.5K | -35.8% | +153.3% | 0.5% | |
Competitors are the stored peer set for HSDT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (18.13M) | (14.07M) | (8.85M) | (11.74M) | (40.89M) |
| Depreciation & Amortization | 374K | 306K | 162K | 60K | 680K |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 1.63M | 2.52M | 9.25M |
| Change in Working Capital | 127K | (1.31M) | (311K) | (8K) | 230K |
| Accounts Receivables | 1K | (103K) | (291K) | (5K) | 0 |
| Inventory | (87K) | (111K) | 137K | (607K) | (85K) |
| Accounts Payables | 369K | (418K) | (103K) | 344K | 1.02M |
| Other Working Capital | (156K) | (674K) | (54K) | 260K | (702K) |
| Other Non-Cash Items | 4.24M | 762K | (3.05M) | (1.87M) | 14.22M |
| Operating Cash Flow | (13.39M) | (14.31M) | (10.42M) | (11.04M) | (16.51M) |
| Capital Expenditures | (54K) | (17K) | (29K) | (5K) | (44.78M) |
| Acquisitions (Net) | 0 | 6K | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | (426.53M) |
| Investing Cash Flow | (56K) | (11K) | (29K) | (5K) | (426.53M) |
| Debt Repayment | 0 | 0 | 0 | 0 | (680K) |
| Common Stock Issued | 21.13M | 17.87M | 1.08M | 6.95M | 467.03M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 0 | 3.99M | (17.11M) |
| Financing Cash Flow | 21.13M | 17.87M | 1.08M | 6.95M | 449.24M |
| Effect of Forex Changes | (8K) | (4K) | 1K | (2K) | 1K |
| Net Change in Cash | 7.67M | 3.54M | (9.37M) | (4.09M) | 6.19M |
| Free Cash Flow | (13.44M) | (14.33M) | (10.45M) | (11.05M) | (61.29M) |
Solana Company
NASDAQ:HSDT
Intrinsic Alpha fair value
Locked
Current Price
$1.63
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.